OTX-201: A Novel Off-the-Shelf In Vivo Anti-CD19 CAR T Platform Designed to Improve Safety and Access to Immune Reset in Autoimmune Diseases (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2089; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
CAR T-Cell Therapy • Preclinical • Immunology
|